TCT-12 Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents

The primary endpoint of head-to-head comparisons of coronary drug-eluting stents is traditionally assessed after 9-12 months. However, the optimal time point for assessment of the primary endpoint remains unsettled. We randomised 2,332 patients to zotarolimus-eluting Endeavor(tm) stent (E-ZES; n=1,